Halaman 3 - Limfoma Dokter Terbaik - TOP-91 dokter

Kepala Dokter di pusat kanker BKZ Solingen – Dr. Fox memimpin tim terbaik di Jerman untuk pengobatan limfoma dengan terapi inovatif.

• Spesialis hematologi, onkologi, dan imunologi sejak 2011
• Pelopor diagnostik molekuler dan terapi bertarget
• Peneliti aktif dalam perawatan penyakit hemato-onkologi
• Anggota American Association for Cancer Research
• Spesialis genetika berkualifikasi sejak 2016

Prof. Dr. Hasan Atilla Ozkan memimpin Asosiasi Aferesis Terapeutik Turki dan berspesialisasi dalam pengobatan limfoma di Rumah Sakit VM Medical Park Pendik.

• Pengalaman lebih dari 20 tahun di bidang hematologi dan penyakit dalam
• Tersertifikasi dalam transplantasi sel induk autolog dan alogenik
• Anggota EBMT (European Society for Blood and Marrow Transplantation)
• Penerima Penghargaan Peneliti Muda 2011 dalam Aferesis Terapeutik

Profesor Drach mengepalai program Multiple Myeloma dan Malignant Lymphoma di salah satu rumah sakit umum terbesar di Eropa – Rumah Sakit Umum Wina (AKH).

• Pengalaman spesialis lebih dari 20 tahun di bidang penyakit dalam dan onkologi
• Menyelesaikan beasiswa penelitian di M.D. Anderson Cancer Center di AS
• Menerbitkan lebih dari 120 karya ilmiah tentang kanker hematologi
• Direktur Klinik Swasta Josefstadt di Wina saat ini
• Anggota dewan Masyarakat Hematologi dan Onkologi Austria

Dr. Eckhart Weidmann berspesialisasi dalam limfoma non-Hodgkin dengan 900+ prosedur yang dilakukan sebagai kepala hematologi di Nordwest Clinic.

• 34 tahun pengalaman di bidang onkologi dan onkohematologi
• Profesor dan kepala Departemen Hematologi
• Melakukan lebih dari 1.100 prosedur selama kariernya
• Ahli dalam perawatan gangguan darah

Diakui sebagai salah satu dokter terbaik Israel oleh Forbes pada 2019-2020, Dr. Gal Goldstein adalah Kepala Onkologi Anak di Rumah Sakit Hadassah.

• Mengambil spesialisasi eksklusif dalam hemato-onkologi anak selama lebih dari 20 tahun
• Ahli dalam perawatan lanjutan seperti transplantasi sumsum tulang haploidentik
• Fokus mendalam pada kanker masa kanak-kanak tertentu, termasuk retinoblastoma
• Anggota aktif perkumpulan onkologi internasional seperti SIOP
• Menerapkan pengobatan presisi untuk mempersonalisasi rencana perawatan

Dr. Abraham Avigdor, MD, is Director of the Institute of Hematology and Co‑Director of the Hematology & Bone Marrow Transplantation Division at Sheba Medical Center. He is an international leader in lymphoma, CAR‑T, and advanced hemato‑oncology with more than 35 years of experience. His clinical focus includes lymphomas, multiple myeloma, and complex blood cancers.

He is a pioneer in CAR‑T integration. He leads cellular therapy and bone marrow transplantation programs (autologous and allogeneic). He also advances stem cell therapies and precision diagnostics, including PET/CT‑based prognostics. His work includes immunotherapy and targeted regimens and the development of innovative, data‑driven protocols.

He collaborates with LYSA, EMCL, and international PET groups. He has authored more than 130 publications. Key roles include Founder and President of the Israeli Lymphoma Working Group, former Chair of the Israeli Lymphoma Study Group, and Senior Lecturer at Tel Aviv University. Education: MD, Ben‑Gurion University; residency, Sheba Medical Center; postdoctoral fellowship, Weizmann Institute. Awards include the Knesset Prize, the Israeli Ministry of Health Award, and the Sackler Prize.

Prof. Avichai Shimoni, MD, is Director of Bone Marrow Transplantation at Sheba Medical Center. He is a hemato-oncologist with over 30 years of experience in bone marrow transplantation, cellular therapies, and advanced blood cancer care.

He leads a high-volume program for complex, high-risk blood cancers. He performs allogeneic and autologous transplants. He also provides CAR T-cell therapy for leukemia, lymphoma, and multiple myeloma. He completed a bone marrow transplantation fellowship at MD Anderson Cancer Center.

He is Chairman of Hematology at Tel Aviv University and a Professor of Hematology. He has authored more than 250 scientific papers. His research focuses on CAR T-cell therapy and stem cell transplantation. He is often listed among Israel's Best Doctors (Forbes 2025 and 2026).

Dr. Hila Magen, MD, leads the Multiple Myeloma and Amyloidosis Unit at Sheba Medical Center. She is a hemato-oncologist with over 35 years of experience. She is a leading Israeli expert in multiple myeloma and plasma cell disorders.

She runs a program that provides personalized care and early access to clinical trials. This includes CAR-T therapy for high-risk and relapsed or refractory myeloma and amyloidosis. Dr. Magen is a principal investigator in point-of-care CAR-T studies. She brings new immunotherapies into routine care.

Training: Fellowships in Multiple Myeloma (UAMS) and Lymphocytic Leukemia (MD Anderson). Academic: Instructor, Tel Aviv University. Research: Author of 100+ publications, contributor to landmark myeloma studies, and reviewer for international journals.

Dr. Iris Kventsel, MD, is a pediatric hemato-oncologist and bone marrow transplant (BMT) specialist at Sheba Medical Center. She is an attending physician in the Pediatric Hemato-Oncology and BMT Division at the Edmond and Lily Safra Children’s Hospital. Her clinical focus is pediatric sarcomas, including Ewing sarcoma, osteosarcoma, and rhabdomyosarcoma.

She provides multidisciplinary care, including transplant and cellular therapies. She also uses current chemotherapy protocols and targeted therapies for complex childhood cancers.

Her research focuses on genetic cancer predisposition, including Li-Fraumeni syndrome, and cancer susceptibility genes. She has published in pediatric oncology, stem cell biology, and surgical oncology (HIPEC). She is on the academic staff at Tel Aviv University. Education: MD, Technion; Pediatrics residency, Assaf HaRofeh; Pediatric Hemato-Oncology fellowship, Sheba.

Prof. Elad Jacoby, MD, heads the Pediatric Cell Therapy Center at Sheba Medical Center. He is the Medical Director of the Advanced Biotherapy Center. He is a pioneer of pediatric CAR T‑cell therapy in Israel. He led one of the first national leukemia programs. He has almost 20 years of clinical and research experience.

He specializes in CAR T‑cell therapy, bone marrow and stem cell transplantation, and high‑risk pediatric leukemias and lymphomas. He leads international clinical trials and has authored over 240 publications. His collaborations include Johns Hopkins Hospital and the U.S. National Cancer Institute. He is an Associate Professor at Tel Aviv University. He received his MD from Tel Aviv University, completed residency at Sheba Medical Center, and fellowships at Johns Hopkins and the National Cancer Institute. He is board‑certified in Pediatrics and in Pediatric Hematology and Oncology. He serves on the IBFM CAR T‑Cell Taskforce and the Sheba Institutional Review Board. He leads the integration of CAR T‑cell therapy with transplantation.

Profesor Bosch adalah pemimpin ternama dunia dalam penelitian Leukemia Limfositik Kronis (LLK) dan limfoma, dengan lebih dari 80 uji klinis yang sedang berlangsung.

• Spesialisasi dalam limfoma dan leukemia limfositik kronis dengan pendekatan pengobatan inovatif
• Presiden kelompok Spanyol untuk studi LLK (GELLC)
• Kepala Hematologi di IOB Institute of Oncology dan Vall d'Hebron University Hospital
• Menerbitkan lebih dari 100 artikel di jurnal medis terkemuka termasuk NEJM dan Nature Medicine

Spesialisasi khusus dalam limfoma, memfokuskan praktiknya pada kanker darah yang kompleks ini di Rambam Medical Center.

• Ahli hematologi dengan keahlian mendalam dalam subtipe limfoma
• Memberikan pengobatan terarah untuk kondisi spesifik ini
• Bertugas di rumah sakit perawatan tersier dan penelitian terkemuka

Karen Drumea adalah seorang spesialis radioterapi onkologi, yang berfokus pada perawatan pasien kanker dengan radiasi di Rambam Medical Center.

• Pengalaman bertahun-tahun di bidang onkologi radiasi dan onkologi umum
• Spesialisasi dalam penggunaan radioterapi untuk mengobati kanker
• Berbasis di Rambam Medical Center di Israel
• Menggabungkan keahlian dalam radiasi dan onkologi medis untuk perawatan pasien

Profesor Zuckerman berspesialisasi secara eksklusif dalam hematologi dan transplantasi sel punca untuk limfoma di Rambam Medical Center.

• Lebih dari 25 tahun pengalaman dalam hematologi dan kedokteran transplantasi
• Berfokus pada transplantasi sumsum tulang dan sel punca untuk pasien limfoma
• Menjabat sebagai dokter senior dan profesor di Rambam Medical Center
• Keahlian dalam kasus-kasus kompleks yang memerlukan protokol transplantasi tingkat lanjut